$PLXP PLx Pharma Inc. Insider Trading
Get free email notifications about insider trading in PLx Pharma Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PLx Pharma Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in PLx Pharma Inc. for free.
CIK Number: 0001497504
IRS Number: 271707962
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: PLXP
Company Address: 9 FISHERS LANE SUITE E SPARTA 07871
Phone number: (973) 409-6541
Former name: Dipexium Pharmaceuticals, LLC, date of change: 2010-07-26
Former name: Dipexium Pharmaceuticals, Inc., date of change: 2014-03-13
Market Capitalization: $15.01M
Prev close: $1.35
Average Daily Volume: 365,645
Days Low: $1.35
Year Low: $1.15
Year High: $17.75
PLx Pharma Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 09 2021 | PLXP | PLx Pharma Inc. | Valentino Michael J | Executive Chairman | Buy | P | 8.00 | 25,000 | 200,000 | 486,690 | 461.7 K to 486.7 K (+5.41 %) |
Dec 15 2020 | PLXP | PLx Pharma Inc. | HADDEN JOHN | Director | Buy | P | 5.49 | 400 | 2,196 | 3,690 | 3.3 K to 3.7 K (+12.16 %) |
Dec 15 2020 | PLXP | PLx Pharma Inc. | HADDEN JOHN | Director | Buy | P | 5.42 | 600 | 3,252 | 3,290 | 2.7 K to 3.3 K (+22.30 %) |
Nov 25 2020 | PLXP | PLx Pharma Inc. | HADDEN JOHN | Director | Buy | P | 5.48 | 500 | 2,738 | 2,690 | 2.2 K to 2.7 K (+22.83 %) |
Nov 20 2020 | PLXP | PLx Pharma Inc. | Valentino Michael J | Executive Chairman | Option Exercise | P | 4.31 | 291,390 | 1,255,891 | 291,390 | |
Nov 20 2020 | PLXP | PLx Pharma Inc. | Valentino Michael J | Executive Chairman | Option Exercise | A | 5.15 | 160,000 | 824,000 | 160,000 | |
Nov 20 2020 | PLXP | PLx Pharma Inc. | Valentino Michael J | Executive Chairman | Buy | P | 3.79 | 264,900 | 1,003,176 | 461,690 | 196.8 K to 461.7 K (+134.61 %) |
Nov 20 2020 | PLXP | PLx Pharma Inc. | Valentino Michael J | Executive Chairman | Option Exercise | P | 4.31 | 291,390 | 1,255,891 | 291,390 | |
Nov 20 2020 | PLXP | PLx Pharma Inc. | Valentino Michael J | Executive Chairman | Option Exercise | A | 5.15 | 160,000 | 824,000 | 160,000 | |
Nov 20 2020 | PLXP | PLx Pharma Inc. | Valentino Michael J | Executive Chairman | Buy | P | 3.79 | 264,900 | 1,003,176 | 461,690 | 196.8 K to 461.7 K (+134.61 %) |
Nov 20 2020 | PLXP | PLx Pharma Inc. | O'Connor Rita M | Chief Financial Off ... | Option Exercise | A | 5.15 | 174,000 | 896,100 | 174,000 | |
Nov 20 2020 | PLXP | PLx Pharma Inc. | HADDEN JOHN | Director | Option Exercise | A | 5.15 | 40,000 | 206,000 | 40,000 | |
Nov 20 2020 | PLXP | PLx Pharma Inc. | Giordano Natasha | Chief Executive Off ... | Option Exercise | A | 5.15 | 350,000 | 1,802,500 | 350,000 | |
Nov 20 2020 | PLXP | PLx Pharma Inc. | Casale Robert | Director | Option Exercise | A | 5.15 | 40,000 | 206,000 | 40,000 | |
Nov 20 2020 | PLXP | PLx Pharma Inc. | CALHOUN KIRK K | Director | Option Exercise | A | 5.15 | 40,000 | 206,000 | 40,000 |